Central noradrenergic mediation of nitrous oxide-induced analgesia in rats

Canadian Journal of Anesthesia

Volumn 45, Issue 11, 1998, Pages 1123-1129

  Fukuhara, Nobuko ^b   Ishikawa, Toshizo ^a   Kinoshita, Hiroyuki ^a   Xiong, Lize ^a   Nakanishi, Osamu ^b  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYUSHU DENTAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANALGESIC AGENT; CLONIDINE; IDAZOXAN; MORPHINE; NALOXONE; NARCOTIC ANALGESIC AGENT; NARCOTIC ANTAGONIST; NITROUS OXIDE; OPIATE RECEPTOR; PRESYNAPTIC RECEPTOR;

ADRENERGIC NERVE; ANIMAL; ARTICLE; BRAIN; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; MALE; NERVE CELL INHIBITION; RAT; REACTION TIME; SENSORY NERVE CELL; SPINAL CORD; SYNAPTIC TRANSMISSION; WISTAR RAT;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ADRENERGIC FIBERS; ANALGESICS; ANALGESICS, OPIOID; ANIMALS; BRAIN; CLONIDINE; DRUG SYNERGISM; IDAZOXAN; MALE; MORPHINE; NALOXONE; NARCOTIC ANTAGONISTS; NEURAL INHIBITION; NEURONS, AFFERENT; NITROUS OXIDE; RATS; RATS, WISTAR; REACTION TIME; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, OPIOID; RECEPTORS, PRESYNAPTIC; SPINAL CORD; SYNAPTIC TRANSMISSION;

EID: 0032195835     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03012404     Document Type: Article

References (25)

1. Kitahata LM, Taub A, Sato I. Lamina-specific suppression of dorsal horn unit activity by nitrous oxide and by hyperventilation. J Pharmacol Exp Ther 1971; 176: 101-8.
2. Berkowitz BA, Finck AD, Ngai SH. Nitrous oxide analgesia: reversal by naloxone and development of tolerance. J Pharmacol Exp Ther 1977; 203: 539-47.
3. Zuniga, JR, Knigge KK, Joseph SA. Central β-endorphin release and recovery after exposure to nitrous oxide in rats. J Oral Maxillofac Surg 1986; 44: 714-8.
4. Quock RM, Kouchich FJ, Tseng L-F. Influence of nitrous oxide upon regional brain levels of methionine-enkephalin-like immunoreactivity in rats. Brain Res Bull 1986; 16: 321-3.
5. Zuniga, J, Joseph S, Knigge K. Nitrous oxide analgesia: partial antagonism by naloxone and total reversal after periaqueductal gray lesions in the rat. Eur J Pharmacol 1987; 142: 51-60.
6. Levine JD, Gordon NC, Fields HL. Naloxone fails to antagonize nitrous oxide analgesia fro clinical pain. Pain 1982; 13: 165-70.
7. Yeung JC, Rudy TA. Multiplicative interaction between narcotic agonisms expressed at spinal and supraspinal sites of antinociceptive action as revealed by concurrent intrathecal and intracerebroventricular injections of morphine. J Pharmacol Exp Ther 1980; 215: 633-42.
8. Stoelting RK. Opiate receptors and endorphins: their role in anesthesiology. Anesth Analg 1980; 59: 874-80.
9. Glazer EJ, Ross LL. Localization of noradrenalinergic terminals in sympathetic preganglionic nuclei of the rat: demonstration by immunocytochemical localization of dopamine-β-hydroxylase. Brain Res 1980; 185: 39-49.
10. 2 agonist binding sites in the rat and human central nervous system: analysis of some functional, anatomic correlates of the pharmacologic effect of clonidine and related adrenergic agents. Brain Res Rev 1984; 319: 69-101.
11. Zemlan FP, Corrigan SA, Pfaff DW. Noradrenergic and serotonergic mediation of spinal analgesia mechanisms. Eur J Pharmacol 1980; 61: 111-24.
12. Yamamoto T, Yaksh TL. Comparison of the antinociceptive effects of pre- and posttreatment with intrathecal morphine and MK801, an NMDA antagonist, on the formalin test in the rat. Anesthesiology 1992; 77: 757-63.
13. Malmberg AB, Yaksh TL. Pharmacology of the spinal action of ketorolac, morphine, ST-91, U50488H, and L-PIA on the formalin test and an isobolographic analysis of the NSAID interaction. Anesthesiology 1993; 79: 270-81.
14. Yaksh TL. Pharmacology of spinal adrenergic systems which modulate spinal nociceptive processing. Pharmacol Biochem Behav 1985; 22: 845-58.
15. 2 adrenergic receptors in the rat. Anesthesiology 1996; 85: 846-52.
16. D'Amour FE, Smith DL. A method for determining loss of pain sensation. J Pharmacol Exp Ther 1941; 72: 74-9.
17. Lisoprawski A, Blanc G, Glowinski J. Activation by stress of the habenulo-interpeduncular substance P neurons in the rat. Neurosci Lett 1981; 25: 47-51.
18. Reddy SVR, Yaksh TL. Spinal noradrenergic terminal system mediates antinociception. Brain Res 1980; 189: 391-401.
19. Yaksh TL, Reddy SVR. Studies in the primate on the analgesic effects associated with intrathecal actions of opiate α-adrenergic agonists and baclofen. Anesthesiology 1981; 54: 451-67.
20. Murata K, Nakagawa I, Kumeta Y, Kitahata LM, Collins JG. Intrathecal clonidine suppresses noxiously evoked activity of spinal wide dynamic range neurons in the cat. Anesth Analg 1989; 69: 185-91.
21. Quock RM, Graczak LM. Influence of narcotic antagonist drugs upon nitrous oxide analgesia in mice. Brain Res 1988; 440: 35-41.
22. Ono H, Mishima A, Ono S, Fukuda H, Vasko MR. Inhibitory effects of clonidine and tizanidine on release of substance P from slices of rat spinal cord and antagonism by α-adrenergic receptor antagonists. Neuropharmacology 1991; 30: 585-9.
23. 2-adrenoceptor modulation of nociception in rat spinal cord: location, effects and interactions with morphine. Eur J Pharmacol 1987; 138: 169-77.
24. Ishikawa T. Nitrous oxide decreases substance P receptor binding in the rat spinal cord. J Neurosurg Anaesth 1989; 1: 316-22.
25. 2-adrenoceptors. Brain Res 1986; 364: 315-30.